Abstract
A woman in her sixties with a normal medical history was admitted to a general medical floor with Neuropathic pain symptoms such as a burning sensation throughout her body (head, back, spine, throat, and tongue with dry mouth, chest, abdomen, kidneys, thighs, toes), inability to eat, urinary incontinence, difficulty wearing clothing, and difficulty leaning on the back. There was a difficulty and delay in diagnosing the patient's condition, which was confirmed to have severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with no respiratory symptoms. The patient's pain did not respond to the covid-19's first-line medications, but it did respond to neuropathic medication with Pregabalin and Alprazolam. Our study shows that Pregabalin could be helpful in relieving the patient’s pain and very effective for treating neuropathic pain with a safe profile, unlike Alprazolam, which interferes with the same stages of sleep, which made her sleep condition worse.
Highlights
The statistics on the coronavirus pandemic are still increasing in the world since the start of the disease [1]
There have not been many reports regarding the symptoms of neuropathic pain among the COVID-19 patients, to our knowledge
The present paper aimed to report in detail an individual case of a patient with neuropathic pain associated with the COVID-19 infection
Summary
The statistics on the coronavirus pandemic are still increasing in the world since the start of the disease [1]. The COVID-19 virus may have neuroinvasive potential and cause neurological complications in patients who suffered from it [3]. Anosmia, dizziness, encephalopathy, stroke [4, 5], and neuropathic pain, which is the rarest neurological association of COVID-19 and was found in only 2.3% (p = 0.07) of hospitalized COVID-19 patients in one observational case study [3]. Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral fibers and central neurons [6]. There have not been many reports regarding the symptoms of neuropathic pain among the COVID-19 patients, to our knowledge. For this reason, the present paper aimed to report in detail an individual case of a patient with neuropathic pain associated with the COVID-19 infection
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Epidemiology and Health Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
